Dasatinib Monohydrate

Spécifications

863127-77-9Numéro CAS

638-874-6Numéro CE

N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;hydrateNom IUPAC

C22H28ClN7O3SFormule chimique

506 g/molMasse molaire

Dasatinib monohydrate; 863127-77-9; BMS 35482503; CHEBI:70839; DTXSID50235486; N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide--water (1/1); N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide--water (1/1); RefChem:1082978; DTXCID50157977; Dasatinib hydrate; Dasatinib (monohydrate); dasatinib.H2O; Dasatinib [USAN]; MFCD08704581; 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-, hydrate (1:1); n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide monohydrate; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide;hydrate; Dasatinib (USAN); BMS 354825-03; Dasatinib hydrate (JAN); DASATINIB HYDRATE [JAN]; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2- hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate; N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide hydrate; BMS-354825 Monohydrate; C22H28ClN7O3S; UNII-RBZ1571X5H; Dasatinib [USAN:INN:BAN:JAN]; 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-, hydrate (1:1); 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-, monohydrate (9CI); BMS 35482503; Dasatinib hydrate; Dasatinib monohydrate; Dasatinib monohydrate?; DASATINIB [JAN]; SPRYCEL (TN); DASATINIB [VANDF]; DASATINIB [EMA EPAR]; SCHEMBL290515; BMS-35482503 hydrate; orb1223826; orb1308590; DASATINIB [ORANGE BOOK]; CHEMBL5416410; SCHEMBL29377489; SCHEMBL29482416; XHXFZZNHDVTMLI-UHFFFAOYSA-N; GLXC-90411; HMS3264K15; HMS3886B19; HMS5085J20; EBC-17138; HY-10181B; s7782; T1448L; AKOS015855318; DASATINIB MONOHYDRATE [WHO-DD]; CCG-269744; FD10821; GS-4248; NSC 759877; SB17285; BD164354; Dasatinib monohydrate - Bio-X trade mark; CS-0019773; D06414; EN300-7359810; Q27139135; N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide;hydrate; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide,hydrateSynonymes